Position in MRNA
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$18
+$15 QoQ
Shares Held
359
+229.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Coston, McIsaac & Partners holds $996 across 6 Biotechnology names. MRNA ranks #4 (1.8% of the industry book) .
All Filings in MRNA
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18 | 359 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $3 | 109 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2 | 109 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3 | 109 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $36 | 1,279 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4 | 119 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $7 | 119 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $16 | 139 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $14 | 139 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $13 | 139 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $14 | 139 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16 | 139 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $21 | 139 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $24 | 139 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $16,436 | 139 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $20,856 | 146 | Shares | Sole | 2022-09-21 | |
| No filing history on record for this holder in this stock. | ||||||